There are 52 papers on adverse pregnancy outcomes in aging research: 1 trial and 21 observational studies in people, 3 in animals, 25 reviews.
52 papers study it107 more mention it23 findings
33 new papers in 30 daysSee all 159 papers on adverse pregnancy outcomes
“APOs were associated with a moderately increased risk of the composite outcome of cardiac arrhythmias and conduction disorders (HRadj 1.22, 95% CI 1.13-1.30)”
- Human trial1
- Humans21
- Animals3
Effects
1Physical activity
no changein humans1downin humans1
1 study
Physical activity
no changein humans1downin humans1
Adverse pregnancy outcomes were not clearly linked with physical activity in fully adjusted regression analyses.
“There were no significant associations between history of APOs and PA levels in the fully adjusted regression analyses.”
Humansin fully adjusted regression analysesfemalesn = 3,771
PloS one
Adverse pregnancy outcomes are linked with lower physical activity in humans (unadjusted / before adjusting for postpartum general health and lifestyle).
“women with a history of APOs had lower levels of PA.”
Humansunadjusted / before adjusting for postpartum general health and lifestylefemalesn = 3,771
PloS one
Associations
20Vascular dementia
upin humans2HR 1.94
2 studies
Vascular dementia
upin humans2HR 1.94
Adverse pregnancy outcomes are associated with vascular dementia in humans (particularly hypertensive disorders of pregnancy).
“The clearest human evidence links adverse pregnancy outcomes (APOs), particularly hypertensive disorders of pregnancy (HDP), to later vascular brain injury and vascular dementia”
Reviewparticularly hypertensive disorders of pregnancybrainfemales
Disentangling Reproductive History and Parenthood in Late-Life Cognitive and Vascular Brain Health
Neuroscience and biobehavioral reviews
Adverse pregnancy outcomes are associated with vascular dementia in humans (parous women with a history of adverse pregnancy outcomes) (Adjusted HR 1.94, 95% CI 1.70–2.21).
“Alzheimer's disease (1·26 [1·04-1·53]; I2=63%), and vascular dementia (1·94 [1·70-2·21]; I2=0%).”
Reviewparous women with a history of adverse pregnancy outcomesfemales
The lancet. Healthy longevity
Composite adverse pregnancy outcome genetic risk score
upin humans1OR 1.3
1 study
Composite adverse pregnancy outcome genetic risk score
upin humans1OR 1.3
Composite adverse pregnancy outcome genetic risk score is associated with adverse pregnancy outcomes in humans (Validation set comprising 40% of the cohort) (OR 1.30 per SD, 95% CI 1.18-1.43; OR 1.69 for top 20% vs. bottom 80%, 95% CI 1.35-2.11).
“In the validation set, the combined APO GRS was associated with a composite of any APO”
HumansValidation set comprising 40% of the cohortper SDfemales
AHA Scientific Sessions 2026 abstract
More on Composite adverse pregnancy outcome genetic risk score
Atrial fibrillation
upin humans1HR 1.39
1 study
Atrial fibrillation
upin humans1HR 1.39
Adverse pregnancy outcomes are associated with atrial fibrillation in humans Following pregnancy (HR 1.39, 95% CI 1.24-1.56).
“APOs were associated with significantly increased long-term risks of HF (HR 1.52, 95% CI 1.24-1.85) and AF (HR 1.39, 95% CI 1.24-1.56).”
ReviewFollowing pregnancyfemales
AHA Scientific Sessions 2026 abstract
Heart failure
upin humans1HR 1.52
1 study
Heart failure
upin humans1HR 1.52
Adverse pregnancy outcomes are associated with heart failure in humans Following pregnancy (HR 1.52, 95% CI 1.24-1.85).
“APOs were associated with significantly increased long-term risks of HF (HR 1.52, 95% CI 1.24-1.85) and AF (HR 1.39, 95% CI 1.24-1.56).”
ReviewFollowing pregnancyfemales
AHA Scientific Sessions 2026 abstract
Stroke
upin humans1HR 1.26
1 study
Stroke
upin humans1HR 1.26
Adverse pregnancy outcomes are associated with stroke in humans (Parous women) (HR 1.26, 95% CI 1.17–1.36).
“APO HR [95%CI] = 1.26 [1.17, 1.36], p < 0.001”
HumansParous womenMedian follow-up: 30.8 yearsfemalesn = 143,958
Adverse Pregnancy Outcomes, Genetic Risk, and Stroke in Parous Women
AHA Scientific Sessions 2026 abstract
Atherosclerotic cardiovascular disease
upin humans1HR 1.52
1 study
Atherosclerotic cardiovascular disease
upin humans1HR 1.52
Adverse pregnancy outcomes are associated with atherosclerotic cardiovascular disease in humans (Pregnancy-evidence cohort without ASCVD before index; adjusted for age and race/ethnicity) (HR 1.52, 95% CI 1.18–1.95).
“APO history was associated with higher incident ASCVD risk after adjustment for age and race/ethnicity: HR 1.52, 95% CI 1.18-1.95.”
HumansPregnancy-evidence cohort without ASCVD before index; adjusted for age and race/ethnicityfemalesn = 36,958
Race and Ethnicity Differences in ASCVD Risk After Adverse Pregnancy Outcomes
AHA Scientific Sessions 2026 abstract
Vascular brain injury
upin humans1
1 study
Vascular brain injury
upin humans1
Adverse pregnancy outcomes are associated with vascular brain injury in humans (particularly hypertensive disorders of pregnancy).
“The clearest human evidence links adverse pregnancy outcomes (APOs), particularly hypertensive disorders of pregnancy (HDP), to later vascular brain injury and vascular dementia”
Reviewparticularly hypertensive disorders of pregnancybrainfemales
Disentangling Reproductive History and Parenthood in Late-Life Cognitive and Vascular Brain Health
Neuroscience and biobehavioral reviews
Cardiac arrhythmias and conduction disorders
upin humans1HR 1.22
1 study
Cardiac arrhythmias and conduction disorders
upin humans1HR 1.22
Adverse pregnancy outcomes are associated with cardiac arrhythmias and conduction disorders in humans (Primiparous women with singleton births and no prior cardiovascular disease) (Adjusted HR 1.22, 95% CI 1.13–1.30).
“APOs were associated with a moderately increased risk of the composite outcome of cardiac arrhythmias and conduction disorders (HRadj 1.22, 95% CI 1.13-1.30)”
HumansPrimiparous women with singleton births and no prior cardiovascular diseaseMedian follow-up of 14 yearsfemalesn = 1,213,474
ESC Congress 2026 abstract
GLP-1 and gip receptor agonists
downin humans1HR 0.38
1 study
GLP-1 and gip receptor agonists
downin humans1HR 0.38
GLP-1 and gip receptor agonists are linked with a lower risk of adverse pregnancy outcomes in humans (pre-conception use versus metformin in PCOS/PMOS) (HR 0.38; 95% CI 0.34-0.41).
“Pre-conception GLP-1/GIP RA use was associated with lower risk of the composite pregnancy outcome (HR 0.38; 95% CI 0.34-0.41).”
Humanspre-conception use versus metformin in PCOS/PMOStwo yearsfemalesn = 48,126
The Journal of clinical endocrinology and metabolism
High-level systolic blood pressure trajectory membership
upin humans1
1 study
High-level systolic blood pressure trajectory membership
upin humans1
Adverse pregnancy outcomes are associated with high-level systolic blood pressure trajectory membership in humans (Postpartum; compared with low-level trajectory membership) (aRR 1.64, 95% CI 1.19–2.66).
“APOs were associated with higher risks of high-level SBP (aRR = 1.64; 95% CI: 1.19-2.66)”
HumansPostpartum; compared with low-level trajectory membershipMean follow-up of 9.2 yearsfemalesn = 1,346
Frontiers in public health
All 20Fewer
Trial sponsors
1 trialPhase 220 people
Maternal-Infantil Vall d’Hebron Hospital
1 trial150 people
Funding
8 grants since 2018National Heart, Lung, and Blood Institute$13.3MNational Institute of Neurological Disorders and Stroke$3.7MNational Institute on Aging$5.8M
National Heart, Lung, and Blood InstituteUniversity of Michigan at Ann Arbor$392K2023–2027
National Institute of Neurological Disorders and StrokeUniversity of Pittsburgh at Pittsburgh$555K2023–2027
Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH)
National Heart, Lung, and Blood InstituteLurie Children's Hospital of Chicago$104K2023–2028
National Institute on AgingUniversity of Pittsburgh at Pittsburgh$1.9M2024–2029
National Heart, Lung, and Blood InstituteBrigham and Women's Hospital$801K2023–2027
National Heart, Lung, and Blood InstituteBrigham and Women's Hospital$143K2022–2024
Coronary Heart Disease in Black Women: The Role of Adverse Pregnancy Outcomes
National Heart, Lung, and Blood InstituteBoston University Medical Campus$122K2016–2021
Adverse pregnancy outcomes and the risk of kidney disease in women: a nationwide cohort study